Patents
Sitemap › A01 - Agriculture; Forestry; Animal husbandry; Hunting; Trapping; Fishing › A01K - Animal husbandry; Care of birds, fishes, insects; Fishing; Rearing or breeding animals, not otherwise provided for; New breeds of animals › A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals
Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
09/2003
09/17/2003EP1343871A2 Isolation and use of solid tumor stem cells
09/17/2003EP1343367A2 Non-human animal disease models
09/17/2003EP1075229B1 Bag for packaging liquid substances for animal artificial insemination
09/17/2003CN1443038A Model for neurodegenerative disease
09/17/2003CN1443037A Production of mammals which produce progeny single sex
09/17/2003CN1442054A Automatic heating and humidifying device for breeding silkworm
09/17/2003CN1442053A Method of storaging and treating fresh silkworm cocoon
09/16/2003US6618977 Method and device for harvesting earthworms
09/12/2003WO2003074699A1 Process for producing physiologically active protein using genetically modified silkworm
09/12/2003WO2003074689A1 Treatment of staphylococcus infections using transgenic expression of a modified lysostaphin gene
09/12/2003WO2003074558A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003WO2003074078A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
09/12/2003WO2003073843A2 Inbred embryonic stem-cell derived mice
09/12/2003WO2003073841A2 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
09/12/2003WO2003048364A3 Ovomucoid promoter and methods of use
09/12/2003WO2002062205A3 Methods for diagnosing and treating heart disease
09/12/2003WO2002059263A9 Transgenic animals comprising a humanized immune system
09/12/2003CA2478636A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003CA2478205A1 Process for producing physiologically active protein using genetically modified silkworm
09/12/2003CA2477596A1 Treatment of staphylococcus infections
09/11/2003US20030172394 Selection and cloning methods
09/11/2003US20030172392 Methods for injecting avian eggs
09/11/2003US20030172391 A transgenic mouse; the enzyme for treating inflammation, smooth muscle contraction; animal models
09/11/2003US20030172390 Mo54 gene disruptions, compositions and methods related thereto
09/11/2003US20030172389 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
09/11/2003US20030172387 Tissue specific expression of exogenous proteins in transgenic chickens
09/11/2003US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides
09/11/2003US20030170888 Chimeric bird from embryonic stem cells
09/11/2003US20030170863 Prevents side effects such as systemic activation of coagulation system, bleeding
09/11/2003US20030170708 Screening for mutants; primer amplification
09/11/2003US20030170647 Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid
09/11/2003US20030170262 Immunogenic detoxified mutant E. coli LT-A toxin
09/11/2003US20030167686 Method and apparatus for butane-enhanced aquatic plant and animal growth
09/11/2003DE20308827U1 Hatching system for hatching of larvae of Cyrysopidae (Planipennia). has an area of corrugated paper with a flat and waved surface and two waved upper surfaces
09/10/2003EP1342729A2 Antibodies and antisense molecules for G-coupled receptor showing selective affinity for ATP
09/10/2003EP1342476A2 FGFR3 as a marker for mesenchymal skeletal progenitor cells and use of cytotoxic conjugates comprising an FGFR3 binding agent for the treatment of cartilagineous bony tumours
09/10/2003EP1342410A2 Transgenic animals lacking a functional galanin gene
09/10/2003EP1341918A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/10/2003EP1341915A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue
09/10/2003EP1341818A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/10/2003EP1341807A2 Interferon-alpha induced gene
09/10/2003EP1341558A2 A novel system for the evaluation of the activity and/or specificity of a viral component
09/10/2003EP1124572B1 Genes and proteins predictive and therapeutic for renal disease and associated disorders
09/10/2003EP0575546B1 Cyclin d1 and its cdna
09/10/2003CN1441652A Microfluidic channel embryo and/or oocyte handling, analysis and biological evaluation
09/10/2003CN1440647A High-yield breeding method and breeding pond for Japanese prawn
09/10/2003CN1440646A Artificial raising method of cuculber amblyseius predatory mite
09/09/2003US6617491 Preparing acetone and methanol extracts of leaves of the plant Acorus calamus; treating Drosophila melanogaster mutant flies in food mixed with phenobarbial or ethanol or extract and ethanol; subjecting to anesthesia; observing
09/09/2003US6617440 Isolated polynucleotide that promotes transcription; gene expression inhibition; used for engineering animals with increased lean meat and promoting muscle growth; treating muscular disorders
09/09/2003US6617430 Ataxin-2 binding proteins
09/09/2003US6617122 Contacting a compound with a polypeptide, in the presence of adenosine triphosphate (ATP) and detecting its binding or hydrolysis of ATP; use in treatment of coronary artery disease
09/09/2003US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent
09/09/2003US6616927 Processes for production of immunoglobulin A in milk
09/04/2003WO2003073098A1 Method of screening psychotropic
09/04/2003WO2003072784A1 Delta 6-desaturases from primulaceae, expressing plants and pufa-containing oils
09/04/2003WO2003072777A1 Embryonically modified animal and method of constructing the same
09/04/2003WO2003072755A2 Transgenic zebrafish models for thrombosis
09/04/2003WO2003072740A2 Novel type-1 cytokine receptor glm-r
09/04/2003WO2003072708A2 Pluripotent cells comprising allogenic nucleus and mitochondria
09/04/2003WO2003071869A1 Method of constructing germline chimeric animal
09/04/2003WO2003064451A3 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE
09/04/2003WO2003030922A3 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2003028446A3 An invertebrate animal model with alzheimer-like pathology for screening and testing molecules
09/04/2003WO2003001212A3 A method for diagnosing a person having multiple sclerosis
09/04/2003WO2003000882A3 Transgenic models for glucose homeostasis comrpising human gsk-3
09/04/2003WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
09/04/2003WO2002101017A3 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor
09/04/2003WO2002097395A3 P-cadherin as a target for anti-cancer therapy
09/04/2003WO2002081737A3 Status of transmissible spongiform encephalopathies
09/04/2003WO2002079238A3 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2002059152A3 Vr-oac, an osmotically activated channel protein, nucleic acids encoding it, and uses thereof
09/04/2003WO2002053775A3 Identification of genetic determinants of polymorphic cyp3a5 expression
09/04/2003WO2002047479A3 Cloning bovines by nuclear transplantation
09/04/2003WO2002046220A3 Sequences upstream of the carp gene, vectors containing them and uses thereof
09/04/2003WO2002036770A3 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits
09/04/2003WO2001096605A3 Methods of dissociating nongenotropic from genotropic activity of steroid receptors
09/04/2003US20030167502 Human monoclonal antibodies to dendritic cells
09/04/2003US20030167500 Methods and compositions for generating a genetically modified animal using lentiviral vectors
09/04/2003US20030167498 Comprises G-protein gamma subunits (GNG4); transgenic mice; dietetics; drug screening
09/04/2003US20030167496 Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequences
09/04/2003US20030167495 Comprises spinocerebellar ataxias (SCAs) genes; neurodegenerative disorders; homologous recombination; genes
09/04/2003US20030167494 Stretch-activated sodium channel modulators
09/04/2003US20030167492 Comprises growth differentiation factor-11 (GDF-11)/transforming growth factors for modulating muscle cell, bone, kidney and adipose tissue growth in foodstuffs
09/04/2003US20030167491 Inositol 1,4,5-triphosphate receptors (IP3R); ankyrin-B; for treatment of cardiac hypertrophy, diabetes, pancreas, respiratory system disorders, blood disorders, vision disorders, endocrine inbalance, and/or pain/inflammation
09/04/2003US20030167489 For transgenic mice that produce high levels of humanizing antibodies; immunoglobulins
09/04/2003US20030167487 Homologous recombination; stem cells; drug screening; platelets
09/04/2003US20030167486 Double transgenic mice overexpressing human beta secretase and human APP-London
09/04/2003US20030167481 Methods for amplifying gentic material and uses thereof
09/04/2003US20030167477 Fusion proteins incorporating lysozyme
09/04/2003US20030166996 Method and apparatus for measuring animal's condition by acquiring and analyzing its biological signals
09/04/2003US20030166908 Seafood protein; measuring water absorption of fish bladder
09/04/2003US20030166897 Diagnosis, therapy cancer; transgenic animal
09/04/2003US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound
09/04/2003US20030166849 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
09/04/2003US20030166247 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures
09/04/2003US20030166239 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques
09/04/2003US20030166221 Megakaryocyte tyrosine kinases; signal transduction in hematopoietic cells
09/04/2003US20030166219 Mitogen-activated protein/extracellular signal-regulated kinases (MAP/ERK)
09/04/2003US20030166189 Peptide of given amino acid sequence; sulfotransferases; useful in labeling agents with tagged sulfur, diagnosis/treatment of cancer, hypertension, renal and neurodegenerative diseases
09/04/2003US20030166187 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
1 ... 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 ... 341